Investors

Liftt SpA

  • Italian VC
  • Headed by Stefano Buono, founder of AAA (acquired by Novartis for $3.9bn)

Prof. Carel Le Roux

  • Among most cited professors worldwide in obesity & diabetes
  • H-index > 70

Carl D. Francis

CEO

  • Raised >$300m
  • Led P2i from startup to world leader
  • Former Eyoto CEO
  • Significant exit and M&A experience
Linkedin Envelope

Dr Tareck Saleh

  • Pioneer in bariatric endoscopy with more than 3,500 gastric balloon procedures in 22 years
  • Owner of renowned weight loss clinics in Dubai & Paris

Nicolaas Verheem

  • Engineer & Founder of Teradek (acquired by Vitec for $35m)
  • Academy Technical Oscar award winner

Garvey Ventures Inc.

  • Founded by John Garvey, an experienced entrepreneur and life sciences investor

Boden Family Investments LLC

  • Founded by Dr Scott Boden, a renowned Professor of Surgery and award-winning researcher

JAZ Chemical Pathologists Ltd

  • Led by Dr Royce Vincent of King’s College London

Pioneer Medical Supplies LLC

  • Leading Middle East distributor of Medical Supplies

+ other investors

Request the investment documents

SAFE Investment Agreement, Pitch Deck, & Executive Summary

Request a Zoom meeting

Signup to our Newsletter

Media

Facebook Twitter Youtube Linkedin

Quick Links

Contact Us

© Copyright Keyron 2022.  All Rights Reserved.  Designed and Developed by SMCSE.

Chris Rowland

Chairman

  • Led $1.1B and $860M exits (Neotract CEO, Given Imaging/PillCam President)
  • $1B+ revenue from 20+ medtech patents

Chris Rowland is one of the most accomplished leaders in the global medtech industry, with over 35 years of experience driving innovation, execution, and strategic growth—particularly in Class III endoscopic and metabolic devices. He served as President of Given Imaging, where he led the company through the $860M PillCam exit to Covidien (now Medtronic), and as CEO of Neotract, which was acquired by Teleflex for $1.1B.

Chris spent 17 years in senior leadership roles at Boston Scientific, gaining rare cross-functional depth across R&D, operations, market development, and global strategy. A prolific inventor, he holds over 20 patents for medical technologies that have generated more than $1 billion in commercial revenue—demonstrating a unique ability to translate clinical innovation into scalable business success.

Chris now serves as Chairman of Keyron’s Board of Directors and supports corporate development, fundraising, and strategic execution—bringing hands-on leadership and global perspective to help scale ForePass into a category-defining solution in metabolic health.